HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Larger Nutritional Studies Needed To Fill Data Gap – HHS Panel

This article was originally published in The Tan Sheet

Executive Summary

USPSTF recommends expanded research and innovative methods to explore the effects and complexities of nutrients. The panel says current research is insufficient to determine whether the use of multivitamins and single-ingredient dietary supplements help prevent CVD or cancer, and recommends against the use of beta-carotene or vitamin E supplements for prevention of the conditions.

You may also be interested in...



Supplement Firms Should Value RCTs, But Also Improve Other Research – CRN

Supplement firms must adapt clinical research methods to accommodate the industry's unique challenges and gain acceptance from mainstream medicine, Council for Responsible Nutrition President and CEO Steve Mister said during the trade group's Day of Science workshop May 3

Vitamin A, C, E Supplements For CVD, Cancer Without Sufficient Evidence

"The evidence is insufficient to recommend for or against the use of supplements" containing vitamins A, C, or E and certain vitamin combinations for the prevention of cancer or cardiovascular disease, the U.S. Preventive Services Task Force has determined

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS124442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel